- Home
- SRZN vs BPRN Comparison
SRZN vs BPRN Comparison
Compare SRZN & BPRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRZN | BPRN |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | 59 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.3M | 292.8M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | SRZN | BPRN |
|---|---|---|
| Price | $31.52 | $44.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $63.50 | $48.25 |
| AVG Volume (30 Days) | ★ 272.4K | 34.8K |
| Earning Date | 11-09-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 3.60% |
| EPS Growth | N/A | ★ 74.84 |
| EPS | N/A | ★ 2.10 |
| Revenue | ★ $3,477,000.00 | N/A |
| Revenue This Year | $187.60 | $4.63 |
| Revenue Next Year | N/A | $4.06 |
| P/E Ratio | ★ N/A | $21.14 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.52 | $31.71 |
| 52 Week High | $37.83 | $46.34 |
Technical Indicators
Market Signals| Indicator | SRZN | BPRN |
|---|---|---|
| Relative Strength Index (RSI) | 59.12 | 55.95 |
| Support Level | $22.61 | $41.99 |
| Resistance Level | $33.96 | $46.16 |
| Average True Range (ATR) | 2.22 | 1.09 |
| MACD | 0.14 | 0.00 |
| Stochastic Oscillator | 65.22 | 55.92 |
Price Performance
Historical ComparisonAbout SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
About BPRN Princeton Bancorp Inc. (PA)
Princeton Bancorp Inc is a full-service financial institution providing personal and business banking services, including checking and savings accounts, as well as a range of lending products such as residential, commercial, construction, and consumer loans, including home equity loans and lines of credit. The Bank operates branches and conducts loan origination activities in areas of the New York City metropolitan area. Its loan portfolio is segmented into commercial real estate (including owner-occupied, non-owner-occupied, and multi-family properties), construction loans (mainly for residential developments), commercial and industrial loans (for business purposes), residential real estate loans (secured by one-to-four family properties), and consumer/HELOC loans.